Tigermed (ASX: 03347) has issued an announcement noting that trading in the shares of its subsidiary Frontage (HKEX: 01521) was temporarily halted on the Hong Kong Stock Exchange from 9:00 a.m. on October 22, 2026.
The suspension is pending the release of an announcement by Frontage containing inside information, in accordance with the company's takeover and merger code.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments